Related Experiment Video
Updated: Nov 18, 2025

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
HMGA1 Induction of miR-103/107 Forms a Negative Feedback Loop to Regulate Autophagy in MPTP Model of Parkinson's
Gehui Li1,2, Wanxian Luo3, Baoyan Wang1
1Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, The National Key Clinical Specialty, Department of Neurosurgery, The Engineering Technology Research Center of Education Ministry of China, The Neurosurgery Institute of Guangdong Province, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Abstract:
Autophagy dysfunction has been directly linked with the onset and progression of Parkinson's disease (PD), but the underlying mechanisms are not well understood. High-mobility group A1 (HMGA1), well-known chromatin remodeling proteins, play pivotal roles in diverse biological processes and diseases. Their function in neural cell death in PD, however, have not yet been fully elucidated. Here, we report that HMGA1 is highly induced during dopaminergic cell death in vitro and mice models of PD in vivo. Functional studies using genetic knockdown of endogenous HMGA1 show that HMGA1 signaling inhibition accelerates neural cell death, at least partially through aggravating MPP+-induced autophagic flux reduction resulting from partial block in autophagic flux at the terminal stages, indicating a novel potential neuroprotective role for HMGA1 in dopaminergic neurons death. MicroRNA-103/107 (miR-103/107) family, which is highly expressed in neuron, coordinately ensures proper end-stage autophagy. We further illustrate that MPP+/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced HMGA1 elevation counterparts the effect of miR-103/107 downregulation by directly binding to their promoters, respectively, sustaining their expression in MPP+-damaged MN9D cells and modulates autophagy through CDK5R1/CDK5 signaling pathway. We also find that HMGA1 is a direct target of miR-103/107 family. Thus, our results suggest that HMGA1 forms a negative feedback loop with miR-103/107-CDK5R1/CDK5 signaling to regulate the MPP+/MPTP-induced autophagy impairment and neural cell death. Collectively, we identify a paradigm for compensatory neuroprotective HMGA1 signaling in dopaminergic neurons that could have important therapeutic implications for PD.
Insights
High-mobility group A1 (HMGA1) shows a protective role in Parkinson's disease (PD) by regulating autophagy. HMGA1 signaling inhibition accelerates neural cell death, highlighting its therapeutic potential for PD.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Autophagy dysfunction is linked to Parkinson's disease (PD) pathogenesis.
- The role of High-mobility group A1 (HMGA1) in PD-related neural cell death is unclear.
Purpose of the Study:
- Investigate the role of HMGA1 in dopaminergic neuron death in PD models.
- Elucidate the regulatory mechanisms involving HMGA1, microRNAs, and autophagy in PD.
Main Methods:
- Utilized in vitro and in vivo PD models.
- Performed genetic knockdown of HMGA1.
- Analyzed autophagy flux, microRNA expression, and protein interactions (HMGA1, miR-103/107, CDK5R1/CDK5).
Main Results:
- HMGA1 is upregulated during dopaminergic cell death in PD models.
- HMGA1 inhibition exacerbates cell death by impairing autophagic flux.
- A negative feedback loop between HMGA1 and miR-103/107-CDK5R1/CDK5 signaling regulates autophagy and cell death.
Conclusions:
- HMGA1 exhibits a compensatory neuroprotective role in dopaminergic neurons.
- The HMGA1-miR-103/107-CDK5R1/CDK5 pathway is a key regulator of autophagy impairment in PD.
- This pathway presents potential therapeutic targets for Parkinson's disease.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation

